June 2018 FDA Recall Nitrofurantoin by Lupin Somerset
D-0927-2018 - Subpotent Drug and Failed Content Uniformity.

This Class II drug recall was voluntarily initiated by Lupin Somerset on June 28, 2018 for the product Nitrofurantoin. The FDA reported the reason for recall as subpotent drug and failed content uniformity.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0927-2018

Reason for Recall
Subpotent Drug and Failed Content Uniformity.
Initiated
06-28-2018
Reported
07-18-2018
Quantity
3456 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide within the US
Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, UPC 343386-450-114, NDC 43386-450-11

Batch or Lot Expiration Information

Lot# : S700065, Exp. 02/2019; 700619, Exp. 08/2019

Affected Packages Involved in this Recall